The cost-effectiveness of expanding the UK newborn bloodspot screening programme to include five additional inborn errors of metabolism

Bessey, A. orcid.org/0000-0001-7677-0309, Chilcott, J. orcid.org/0000-0003-1231-7817, Pandor, A. orcid.org/0000-0003-2552-5260 et al. (1 more author) (2020) The cost-effectiveness of expanding the UK newborn bloodspot screening programme to include five additional inborn errors of metabolism. International Journal of Neonatal Screening, 6 (4). 93.

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2020 The Authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Keywords: glutaric aciduria type 1; homocystinuria; isovaleric acidaemia; long-chain hydroxyacyl CoA dehydrogenase deficiency; maple syrup urine disease; inborn errors of metabolism; cost-effectiveness; economic; newborn screening; neonatal screening
Dates:
  • Accepted: 13 November 2020
  • Published (online): 20 November 2020
  • Published: 20 November 2020
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Sheffield Centre for Health and Related Research
Depositing User: Symplectic Sheffield
Date Deposited: 26 Nov 2020 12:03
Last Modified: 26 Nov 2020 12:33
Status: Published
Publisher: MDPI AG
Refereed: Yes
Identification Number: https://doi.org/10.3390/ijns6040093

Download

Share / Export

Statistics